Intec Pharma - 48 Year Dividend History | NTEC

Historical dividend payout and yield for Intec Pharma (NTEC) since 1971. The current TTM dividend payout for Intec Pharma (NTEC) as of June 19, 2019 is $0.00. The current dividend yield for Intec Pharma as of June 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.137B $0.000B
Intec Pharma Ltd. is a biopharmaceutical company. The company focused on developing drugs through proprietary Accordion Pill platform technology. Its product candidates in clinical trial stages consists of Accordion Pill Carbidopa/Levodopa developed for the indication of treatment of Parkinson's disease symptoms; Accordion Pill Zaleplon is being developed for the indication of treatment of insomnia, including sleep induction and the improvement of sleep maintenance. Intec Pharma Ltd. is based in JERUSALEM, Israel.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $111.478B 12.60
Gilead Sciences (GILD) United States $87.024B 10.57
Bio-Techne Corp (TECH) United States $7.996B 54.56